Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,321 to 1,340 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Single-Cell Profiling Reveals Heterogeneity of Primary and Lymph Node Metastatic Tumors and Immune Cell Populations and Discovers Important Prognostic Significance of CCDC43 in Oral Squamous Cell Carcinoma. | Front Immunol | 2022 | 35401551 | PubTator, text mining | PubMed |
| ACE2 Serum Levels as Predictor of Infectability and Outcome in COVID-19. | Front Immunol | 2022 | 35401548 | PubTator, text mining | PubMed |
| Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review. | Front Immunol | 2022 | 35401519 | PubTator, text mining | PubMed |
| Potential of nuclear magnetic resonance metabolomics in the study of prostate cancer. | Indian J Urol | 2022 | 35400867 | PubTator, text mining | PubMed |
| Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC. | Clin Cancer Res | 2022 | 35394499 | PubTator, text mining | PubMed |
| Hepatocellular carcinoma-infiltrating γδ T cells are functionally defected and allogenic Vδ2+ γδ T cell can be a promising complement. | Clin Transl Med | 2022 | 35390227 | PubTator, text mining | PubMed |
| Single-cell RNA-seq reveals cell type-specific molecular and genetic associations to lupus. | Science | 2022 | 35389781 | PubTator, text mining | PubMed |
| Intensive single-cell analysis reveals immune-cell diversity among healthy individuals. | Life Sci Alliance | 2022 | 35383111 | PubTator, text mining | PubMed |
| Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control. | J Clin Invest | 2022 | 35380989 | PubTator, text mining | PubMed |
| Innate lymphoid cells: NK and cytotoxic ILC3 subsets infiltrate metastatic breast cancer lymph nodes. | Oncoimmunology | 2022 | 35371620 | PubTator, text mining | PubMed |
| Multifunctional role of exosomes in viral diseases: From transmission to diagnosis and therapy. | Cell Signal | 2022 | 35367363 | PubTator, text mining | PubMed |
| T-cell surveillance of the human brain in health and multiple sclerosis. | Semin Immunopathol | 2022 | 35364699 | PubTator, text mining | PubMed |
| Tissue-Dependent Adaptations and Functions of Innate Lymphoid Cells. | Front Immunol | 2022 | 35359972 | PubTator, text mining | PubMed |
| Identification of Long Noncoding RNAs Associated With the Clinicopathological Features of Papillary Thyroid Carcinoma Complicated With Hashimoto's Thyroiditis. | Front Oncol | 2022 | 35359359 | PubTator, text mining | PubMed |
| Global transcriptomic characterization of T cells in individuals with chronic HIV-1 infection. | Cell Discov | 2022 | 35351857 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the PRDXs Family in Head and Neck Squamous Cell Carcinoma. | Front Oncol | 2022 | 35350568 | PubTator, text mining | PubMed |
| Urinary galectin-3 binding protein (G3BP) as a biomarker for disease activity and renal pathology characteristics in lupus nephritis. | Arthritis Res Ther | 2022 | 35346341 | PubTator, text mining | PubMed |
| Multi-omics & pathway analysis identify potential roles for tumor N-acetyl aspartate accumulation in murine models of castration-resistant prostate cancer. | iScience | 2022 | 35345457 | PubTator, text mining | PubMed |
| Single-cell temporal analysis of natural dengue infection reveals skin-homing lymphocyte expansion one day before defervescence. | iScience | 2022 | 35345453 | PubTator, text mining | PubMed |
| Aprotinin treatment against SARS-CoV-2: A randomized phase III study to evaluate the safety and efficacy of a pan-protease inhibitor for moderate COVID-19. | Eur J Clin Invest | 2022 | 35342931 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=67